Diabetic neuropathy and zinc therapy.
Bangladesh Med Res Counc Bull
;
2005 Aug; 31(2): 62-7
Article
Dans Anglais
| IMSEAR
| ID: sea-392
ABSTRACT
This was a double blind study conducted on 60 subjects; 20 age and sex matched healthy controls (Group-I), 20 patients of diabetes mellitus with neuropathy who received placebo for 6 weeks (Group-IIA); and 20 patients of diabetes mellitus with neuropathy who were given oral 660 mg zinc sulphate for 6 weeks (Group-IIB). Serum zinc level, fasting blood sugar (FBS), blood sugar 2 hour after breakfast (2HABF) and motor nerve conduction velocity (MNCV) were estimated on day 0 and after 6 weeks in all subjects. Serum zinc levels were significantly low (p<0.001) in group II-A and II-B as compared to healthy controls (group-I) at base line. After 6 weeks the changes in pre and post therapy values of FBS, 2HABF and MNCV (median and common peroneal nerve) were highly significant (p<0.001) for group II-B alone with insignificant change (p>0.05) in group II-A. Therefore, zinc therapy helps in achieving better glycemic control and improvement in peripheral neuropathy as assessed by MNCV.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Placebo
/
Astringents
/
Bangladesh
/
Femelle
/
Humains
/
Mâle
/
Méthode en double aveugle
/
Sulfate de zinc
/
Adulte
/
Neuropathies diabétiques
Type d'étude:
Essai clinique contrôlé
Pays comme sujet:
Asie
langue:
Anglais
Texte intégral:
Bangladesh Med Res Counc Bull
Année:
2005
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS